281 related articles for article (PubMed ID: 16480697)
1. Lipid and lipoprotein dysregulation in insulin resistant states.
Avramoglu RK; Basciano H; Adeli K
Clin Chim Acta; 2006 Jun; 368(1-2):1-19. PubMed ID: 16480697
[TBL] [Abstract][Full Text] [Related]
2. Influence of plasma free fatty acids on lipoprotein synthesis and diabetic dyslipidemia.
Julius U
Exp Clin Endocrinol Diabetes; 2003 Aug; 111(5):246-50. PubMed ID: 12951628
[TBL] [Abstract][Full Text] [Related]
3. Insulin resistance, the insulin resistance syndrome, and cardiovascular disease.
Reaven GM
Panminerva Med; 2005 Dec; 47(4):201-10. PubMed ID: 16489319
[TBL] [Abstract][Full Text] [Related]
4. Inflammatory NF-kappaB activation promotes hepatic apolipoprotein B100 secretion: evidence for a link between hepatic inflammation and lipoprotein production.
Tsai J; Zhang R; Qiu W; Su Q; Naples M; Adeli K
Am J Physiol Gastrointest Liver Physiol; 2009 Jun; 296(6):G1287-98. PubMed ID: 19342510
[TBL] [Abstract][Full Text] [Related]
5. Intestinal assembly and secretion of highly dense/lipid-poor apolipoprotein B48-containing lipoprotein particles in the fasting state: evidence for induction by insulin resistance and exogenous fatty acids.
Guo Q; Avramoglu RK; Adeli K
Metabolism; 2005 May; 54(5):689-97. PubMed ID: 15877301
[TBL] [Abstract][Full Text] [Related]
6. Regulation of plasma triglycerides in insulin resistance and diabetes.
Ginsberg HN; Zhang YL; Hernandez-Ono A
Arch Med Res; 2005; 36(3):232-40. PubMed ID: 15925013
[TBL] [Abstract][Full Text] [Related]
7. Triglycerides and gallstone formation.
Smelt AH
Clin Chim Acta; 2010 Nov; 411(21-22):1625-31. PubMed ID: 20699090
[TBL] [Abstract][Full Text] [Related]
8. [Disorders of lipid metabolism in insulin resistance].
Müller-Wieland D; Krone W
Herz; 1995 Feb; 20(1):33-46. PubMed ID: 7713475
[TBL] [Abstract][Full Text] [Related]
9. Overproduction of very low-density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome.
Adiels M; Olofsson SO; Taskinen MR; Borén J
Arterioscler Thromb Vasc Biol; 2008 Jul; 28(7):1225-36. PubMed ID: 18565848
[TBL] [Abstract][Full Text] [Related]
10. Oleate-mediated stimulation of microsomal triglyceride transfer protein (MTP) gene promoter: implications for hepatic MTP overexpression in insulin resistance.
Qiu W; Taghibiglou C; Avramoglu RK; Van Iderstine SC; Naples M; Ashrafpour H; Mhapsekar S; Sato R; Adeli K
Biochemistry; 2005 Mar; 44(8):3041-9. PubMed ID: 15723548
[TBL] [Abstract][Full Text] [Related]
11. Tumor necrosis factor-alpha directly stimulates the overproduction of hepatic apolipoprotein B100-containing VLDL via impairment of hepatic insulin signaling.
Qin B; Anderson RA; Adeli K
Am J Physiol Gastrointest Liver Physiol; 2008 May; 294(5):G1120-9. PubMed ID: 18372392
[TBL] [Abstract][Full Text] [Related]
12. Enhanced cellular uptake of remnant high-density lipoprotein particles: a mechanism for high-density lipoprotein lowering in insulin resistance and hypertriglyceridemia.
Xiao C; Watanabe T; Zhang Y; Trigatti B; Szeto L; Connelly PW; Marcovina S; Vaisar T; Heinecke JW; Lewis GF
Circ Res; 2008 Jul; 103(2):159-66. PubMed ID: 18556574
[TBL] [Abstract][Full Text] [Related]
13. Secretion of atherogenic risk factor apolipoprotein B-100 is increased by a potential mechanism of JNK/PKC-mediated insulin resistance in liver cells.
Jin UH; Kang YJ; Chang YC; Kim CH
J Cell Biochem; 2008 Feb; 103(3):908-19. PubMed ID: 17647275
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of microsomal triglyceride transfer protein improves insulin sensitivity and reduces atherogenic risk in Zucker fatty rats.
Dhote V; Joharapurkar A; Kshirsagar S; Dhanesha N; Patel V; Patel A; Raval S; Jain M
Clin Exp Pharmacol Physiol; 2011 May; 38(5):338-44. PubMed ID: 21401695
[TBL] [Abstract][Full Text] [Related]
15. Intestinal lipoprotein overproduction in insulin-resistant states.
Adeli K; Lewis GF
Curr Opin Lipidol; 2008 Jun; 19(3):221-8. PubMed ID: 18460911
[TBL] [Abstract][Full Text] [Related]
16. Multiple factors and pathways involved in hepatic very low density lipoprotein-apoB100 overproduction in Otsuka Long-Evans Tokushima Fatty rats.
Qin B; Anderson RA; Kuzuya T; Kitaura Y; Shimomura Y
Atherosclerosis; 2012 Jun; 222(2):409-16. PubMed ID: 22546076
[TBL] [Abstract][Full Text] [Related]
17. Abnormal hepatic apolipoprotein B metabolism in type 2 diabetes.
Vergès B
Atherosclerosis; 2010 Aug; 211(2):353-60. PubMed ID: 20189175
[TBL] [Abstract][Full Text] [Related]
18. Altered triglyceride-rich lipoprotein production in Zucker diabetic fatty rats.
Chirieac DV; Collins HL; Cianci J; Sparks JD; Sparks CE
Am J Physiol Endocrinol Metab; 2004 Jul; 287(1):E42-9. PubMed ID: 14970003
[TBL] [Abstract][Full Text] [Related]
19. [Dyslipoproteinemia and metabolic syndrome. Effects of insulin resistance and hyperinsulinemia on lipid metabolism].
Krone W; Müller-Wieland D; Wirth H
Fortschr Med; 1992 Dec; 110(34):645-8. PubMed ID: 1483617
[TBL] [Abstract][Full Text] [Related]
20. The relationship between insulin resistance and dyslipidaemia in cigarette smokers.
Farin HM; Abbasi F; Kim SH; Lamendola C; McLaughlin T; Reaven GM
Diabetes Obes Metab; 2007 Jan; 9(1):65-9. PubMed ID: 17199720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
